Moolec Science (MLEC) EBIT (2022 - 2024)

Moolec Science has disclosed EBIT across 3 years of filings, most recently posting -$2.1 million for Q4 2024.

• EBIT for Q4 2024 came in at -$2.1 million, down 14.86% year-over-year; the trailing twelve-month figure through Dec 2024 was $19.2 million (down 79.84% YoY), and the FY2024 annual result was $19.3 million, down 80.33% from the prior year.
• EBIT came in at -$2.1 million for Q4 2024 at Moolec Science, up from -$2.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $100.6 million in Q2 2023 to a low of -$2.3 million in Q3 2023.
• The 3-year median for EBIT is -$1.0 million (2022), against an average of $12.2 million.
• Peak annual rise in EBIT reached 196.44% in 2023, while the deepest fall reached 279.55% in 2023.
• Moolec Science's EBIT stood at -$472416.0 in 2022, then tumbled by 279.55% to -$1.8 million in 2023, then retreated by 14.86% to -$2.1 million in 2024.
• The last three EBIT figures came in at -$2.1 million (Q4 2024), -$2.1 million (Q3 2024), and $25.4 million (Q2 2024), per Business Quant data.